The Inhibition of UBC13 Expression and Blockage of the DNMT1-CHFR-Aurora a Pathway Contribute to Paclitaxel Resistance in Ovarian Cancer

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-017-0137-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Inhibition of Aurora-A Kinase Induces Cell Cycle Arrest in Epithelial Ovarian Cancer Stem Cells by Affecting NFĸB Pathway

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2011English

Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

P53 and PTEN Expression Contribute to the Inhibition of EGFR Downstream Signaling Pathway by Cetuximab

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression

Oncotarget
Oncology
2019English

Phosphorylation of Caspase-9 at Thr125 Directs Paclitaxel Resistance in Ovarian Cancer

Oncotarget
Oncology
2017English

Inhibition of Synuclein-Γ Expression Increases the Sensitivity of Breast Cancer Cells to Paclitaxel Treatment

International Journal of Oncology
Cancer ResearchOncology
2006English

Effect of Combined Inhibition of P110 Alpha PI3K Isoform and STAT3 Pathway in Ovarian Cancer Platinum-Based Resistance

Oncotarget
Oncology
2018English

Inhibition of Pregnane X Receptor Pathway Contributes to the Cell Growth Inhibition and Apoptosis of Anticancer Agents in Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy